EcoDrugPlus

Ensembl ID : ENSOMYG00000046993
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSOMYG00000021865
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSOMYG00000047089
Gene Symbol: -
Cross references: -
174 Possible Orthologues:

Ensembl ID : ENSOMYG00000047242
Gene Symbol: -
Cross references: -
373 Possible Orthologues:

Ensembl ID : ENSOMYG00000050421
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSOMYG00000020836
Gene Symbol: -
Cross references: -
350 Possible Orthologues:

Ensembl ID : ENSOMYG00000050794
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSOMYG00000050866
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSOMYG00000050782
Gene Symbol: -
Cross references: -
97 Possible Orthologues:

Ensembl ID : ENSOMYG00000051231
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSOMYG00000052426
Gene Symbol: -
Cross references: -
97 Possible Orthologues:

Ensembl ID : ENSOMYG00000053822
Gene Symbol: -
Cross references: -
13 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).